{
    "info": {
        "nct_id": "NCT05059522",
        "official_title": "Avelumab Master Protocol: An Open-label Continuation Study for Participants Continuing From Pfizer-sponsored Avelumab Clinical Studies.",
        "inclusion_criteria": "1. Any participant who is receiving study treatment and deriving significant clinical benefit or is in the safety and/or survival follow-up period in a Pfizer-sponsored Avelumab Parent Study.\n2. Participants must agree to follow the reproductive criteria.\n3. Participants must be willing and able to comply with all scheduled visits, treatment plan, and other study procedures.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Female participants who are pregnant or breastfeeding.\n2. Any medical reason that, in the opinion of the Investigator or Sponsor, precludes the participant from inclusion in the study.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "3. Participants must be willing and able to comply with all scheduled visits, treatment plan, and other study procedures.",
            "criterions": [
                {
                    "exact_snippets": "Participants must be willing and able to comply with all scheduled visits, treatment plan, and other study procedures.",
                    "criterion": "compliance with study procedures",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Any participant who is receiving study treatment and deriving significant clinical benefit or is in the safety and/or survival follow-up period in a Pfizer-sponsored Avelumab Parent Study.",
            "criterions": [
                {
                    "exact_snippets": "receiving study treatment",
                    "criterion": "study treatment receipt",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "deriving significant clinical benefit",
                    "criterion": "clinical benefit from study treatment",
                    "requirements": [
                        {
                            "requirement_type": "significance",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "in the safety and/or survival follow-up period",
                    "criterion": "follow-up period status",
                    "requirements": [
                        {
                            "requirement_type": "period",
                            "expected_value": [
                                "safety follow-up",
                                "survival follow-up"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "in a Pfizer-sponsored Avelumab Parent Study",
                    "criterion": "enrollment in Pfizer-sponsored Avelumab Parent Study",
                    "requirements": [
                        {
                            "requirement_type": "enrollment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Participants must agree to follow the reproductive criteria.",
            "criterions": [
                {
                    "exact_snippets": "Participants must agree to follow the reproductive criteria",
                    "criterion": "reproductive criteria",
                    "requirements": [
                        {
                            "requirement_type": "agreement to follow",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "2. Any medical reason that, in the opinion of the Investigator or Sponsor, precludes the participant from inclusion in the study.",
            "criterions": [
                {
                    "exact_snippets": "Any medical reason that, in the opinion of the Investigator or Sponsor, precludes the participant from inclusion in the study.",
                    "criterion": "medical reason precluding study inclusion",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "investigator or sponsor opinion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Female participants who are pregnant or breastfeeding.",
            "criterions": [
                {
                    "exact_snippets": "Female participants who are pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}